{"entity":{"type":"insider","cik":"0001629383","url":"/insider/0001629383","json_url":"/insider/0001629383.json","name":"Boyce Sarah","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":27,"first":"2016-01-19","last":"2026-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Boyce Sarah","source":"filing","n_filings":27,"first_seen":"2016-01-19","last_seen":"2026-01-23"}],"transactions":[{"id":5906930,"accession":"0001599901-26-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-26-000025","line_url":"/filing/0001599901-26-000025","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14387.0,"shares_display":"14,387","price_per_share":72.45,"price_display":"72.45","price_state":"stated","total_value":1042338.15,"total_display":"1,042,338.15","total_whole":"1,042,338","shares_owned_after":269007.0,"shares_owned_after_display":"269,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-23","scope":"insider","n_lines":2},{"id":5862959,"accession":"0001599901-26-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-26-000014","line_url":"/filing/0001599901-26-000014#line-1","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8576.0,"shares_display":"8,576","price_per_share":72.23,"price_display":"72.23","price_state":"stated","total_value":619444.48,"total_display":"619,444.48","total_whole":"619,444","shares_owned_after":283394.0,"shares_owned_after_display":"283,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-09","scope":"insider"},{"id":4823233,"accession":"0001599901-25-000175","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-25-000175","line_url":"/filing/0001599901-25-000175#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":49.9487,"price_display":"49.95","price_state":"stated","total_value":2497435.0,"total_display":"2,497,435.00","total_whole":"2,497,435","shares_owned_after":305871.0,"shares_owned_after_display":"305,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-05","scope":"insider"},{"id":5093822,"accession":"0001599901-25-000168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-25-000168","line_url":"/filing/0001599901-25-000168#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":49.388,"price_display":"49.39","price_state":"stated","total_value":1234700.0,"total_display":"1,234,700.00","total_whole":"1,234,700","shares_owned_after":305871.0,"shares_owned_after_display":"305,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-28","filed_date":"2025-08-29","scope":"insider"},{"id":4600284,"accession":"0001599901-25-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-25-000073","line_url":"/filing/0001599901-25-000073#line-1","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31540.0,"shares_display":"31,540","price_per_share":31.0578,"price_display":"31.06","price_state":"stated","total_value":979563.012,"total_display":"979,563.01","total_whole":"979,563","shares_owned_after":305871.0,"shares_owned_after_display":"305,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":4652749,"accession":"0001599901-25-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-25-000035","line_url":"/filing/0001599901-25-000035","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10397.0,"shares_display":"10,397","price_per_share":28.593962008271617,"price_display":"28.59","price_state":"stated","total_value":297291.423,"total_display":"297,291.42","total_whole":"297,291","shares_owned_after":337411.0,"shares_owned_after_display":"337,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider","n_lines":2},{"id":3186192,"accession":"0001599901-24-000205","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-24-000205","line_url":"/filing/0001599901-24-000205#line-1","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31855.0,"shares_display":"31,855","price_per_share":32.66,"price_display":"32.66","price_state":"stated","total_value":1040384.3,"total_display":"1,040,384.30","total_whole":"1,040,384","shares_owned_after":265308.0,"shares_owned_after_display":"265,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-19","scope":"insider"},{"id":2224643,"accession":"0001599901-24-000158","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001599901-24-000158","line_url":"/filing/0001599901-24-000158#line-3","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32880.0,"shares_display":"32,880","price_per_share":44.0001,"price_display":"44.00","price_state":"stated","total_value":1446723.288,"total_display":"1,446,723.29","total_whole":"1,446,723","shares_owned_after":234663.0,"shares_owned_after_display":"234,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-23","filed_date":"2024-09-23","scope":"insider"},{"id":2968877,"accession":"0001599901-24-000127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000127","line_url":"/filing/0001599901-24-000127#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":43.3508,"price_display":"43.35","price_state":"stated","total_value":1213822.4,"total_display":"1,213,822.40","total_whole":"1,213,822","shares_owned_after":205043.0,"shares_owned_after_display":"205,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-06","filed_date":"2024-08-07","scope":"insider"},{"id":2488492,"accession":"0001599901-24-000115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000115","line_url":"/filing/0001599901-24-000115#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":39.9315,"price_display":"39.93","price_state":"stated","total_value":1118082.0,"total_display":"1,118,082.00","total_whole":"1,118,082","shares_owned_after":205043.0,"shares_owned_after_display":"205,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-07-11","scope":"insider"},{"id":2429108,"accession":"0001599901-24-000109","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001599901-24-000109","line_url":"/filing/0001599901-24-000109#line-3","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32074.0,"shares_display":"32,074","price_per_share":39.1295,"price_display":"39.13","price_state":"stated","total_value":1255039.583,"total_display":"1,255,039.58","total_whole":"1,255,040","shares_owned_after":142543.0,"shares_owned_after_display":"142,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-20","scope":"insider"},{"id":2567439,"accession":"0001599901-24-000093","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001599901-24-000093","line_url":"/filing/0001599901-24-000093#line-6","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35767.0,"shares_display":"35,767","price_per_share":40.0784,"price_display":"40.08","price_state":"stated","total_value":1433484.1328,"total_display":"1,433,484.13","total_whole":"1,433,484","shares_owned_after":112117.0,"shares_owned_after_display":"112,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2024-06-14","scope":"insider"},{"id":2567433,"accession":"0001599901-24-000093","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001599901-24-000093","line_url":"/filing/0001599901-24-000093#line-4","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":164233.0,"shares_display":"164,233","price_per_share":40.076,"price_display":"40.08","price_state":"stated","total_value":6581801.708,"total_display":"6,581,801.71","total_whole":"6,581,802","shares_owned_after":112117.0,"shares_owned_after_display":"112,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-06-14","scope":"insider"},{"id":2567424,"accession":"0001599901-24-000093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000093","line_url":"/filing/0001599901-24-000093#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":35.7302,"price_display":"35.73","price_state":"stated","total_value":3573020.0,"total_display":"3,573,020.00","total_whole":"3,573,020","shares_owned_after":112117.0,"shares_owned_after_display":"112,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-14","scope":"insider"},{"id":2703094,"accession":"0001599901-24-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000077","line_url":"/filing/0001599901-24-000077#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":27.4207,"price_display":"27.42","price_state":"stated","total_value":767779.6,"total_display":"767,779.60","total_whole":"767,780","shares_owned_after":112117.0,"shares_owned_after_display":"112,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-05","scope":"insider"},{"id":3057438,"accession":"0001599901-24-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000064","line_url":"/filing/0001599901-24-000064#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":25.5375,"price_display":"25.54","price_state":"stated","total_value":715050.0,"total_display":"715,050.00","total_whole":"715,050","shares_owned_after":112117.0,"shares_owned_after_display":"112,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-07","filed_date":"2024-05-07","scope":"insider"},{"id":2092576,"accession":"0001599901-24-000049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000049","line_url":"/filing/0001599901-24-000049#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":26.2471,"price_display":"26.25","price_state":"stated","total_value":734918.8,"total_display":"734,918.80","total_whole":"734,919","shares_owned_after":112117.0,"shares_owned_after_display":"112,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-02","filed_date":"2024-04-03","scope":"insider"},{"id":2162693,"accession":"0001599901-24-000040","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001599901-24-000040","line_url":"/filing/0001599901-24-000040#line-4","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":22.6315,"price_display":"22.63","price_state":"stated","total_value":633682.0,"total_display":"633,682.00","total_whole":"633,682","shares_owned_after":112117.0,"shares_owned_after_display":"112,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-12","filed_date":"2024-03-12","scope":"insider"},{"id":2162683,"accession":"0001599901-24-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000040","line_url":"/filing/0001599901-24-000040#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84000.0,"shares_display":"84,000","price_per_share":21.3894,"price_display":"21.39","price_state":"stated","total_value":1796709.6,"total_display":"1,796,709.60","total_whole":"1,796,710","shares_owned_after":112117.0,"shares_owned_after_display":"112,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-12","scope":"insider"},{"id":2359116,"accession":"0001599901-24-000038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000038","line_url":"/filing/0001599901-24-000038#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84000.0,"shares_display":"84,000","price_per_share":20.1346,"price_display":"20.13","price_state":"stated","total_value":1691306.4,"total_display":"1,691,306.40","total_whole":"1,691,306","shares_owned_after":112117.0,"shares_owned_after_display":"112,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":2290520,"accession":"0001599901-24-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000011","line_url":"/filing/0001599901-24-000011#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5092.0,"shares_display":"5,092","price_per_share":10.13,"price_display":"10.13","price_state":"stated","total_value":51581.96,"total_display":"51,581.96","total_whole":"51,582","shares_owned_after":44008.0,"shares_owned_after_display":"44,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-23","scope":"insider"},{"id":8677547,"accession":"0001209191-23-007092","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-007092","line_url":"/filing/0001209191-23-007092#line-6","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3221.0,"shares_display":"3,221","price_per_share":24.26,"price_display":"24.26","price_state":"stated","total_value":78141.46,"total_display":"78,141.46","total_whole":"78,141","shares_owned_after":53352.0,"shares_owned_after_display":"53,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-03","filed_date":"2023-02-03","scope":"insider"},{"id":8677544,"accession":"0001209191-23-007092","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-007092","line_url":"/filing/0001209191-23-007092#line-4","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45879.0,"shares_display":"45,879","price_per_share":24.3628,"price_display":"24.36","price_state":"stated","total_value":1117740.9012,"total_display":"1,117,740.90","total_whole":"1,117,741","shares_owned_after":53352.0,"shares_owned_after_display":"53,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-03","scope":"insider"},{"id":8677540,"accession":"0001209191-23-007092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-007092","line_url":"/filing/0001209191-23-007092#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":24.2716,"price_display":"24.27","price_state":"stated","total_value":21844.44,"total_display":"21,844.44","total_whole":"21,844","shares_owned_after":53352.0,"shares_owned_after_display":"53,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":6981614,"accession":"0000899243-22-035698","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-035698","line_url":"/filing/0000899243-22-035698#line-2","is_derivative":false,"issuer_cik":"0001629383","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001629383","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.92,"price_display":"2.92","price_state":"stated","total_value":43800.0,"total_display":"43,800.00","total_whole":"43,800","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-11-14","scope":"insider"},{"id":6981609,"accession":"0000899243-22-035698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035698","line_url":"/filing/0000899243-22-035698#line-1","is_derivative":false,"issuer_cik":"0001629383","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001629383","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21000.0,"shares_display":"21,000","price_per_share":2.7427,"price_display":"2.74","price_state":"stated","total_value":57596.7,"total_display":"57,596.70","total_whole":"57,597","shares_owned_after":21000.0,"shares_owned_after_display":"21,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-09","filed_date":"2022-11-14","scope":"insider"},{"id":6574237,"accession":"0001209191-22-047760","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-047760","line_url":"/filing/0001209191-22-047760#line-4","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14855.0,"shares_display":"14,855","price_per_share":23.069,"price_display":"23.07","price_state":"stated","total_value":342689.995,"total_display":"342,690.00","total_whole":"342,690","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-25","filed_date":"2022-08-26","scope":"insider"},{"id":6574232,"accession":"0001209191-22-047760","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-047760","line_url":"/filing/0001209191-22-047760#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35045.0,"shares_display":"35,045","price_per_share":22.7971,"price_display":"22.80","price_state":"stated","total_value":798924.3695,"total_display":"798,924.37","total_whole":"798,924","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-26","scope":"insider"},{"id":6786751,"accession":"0001209191-22-046520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046520","line_url":"/filing/0001209191-22-046520#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":22.47,"price_display":"22.47","price_state":"stated","total_value":2247.0,"total_display":"2,247.00","total_whole":"2,247","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":4707772,"accession":"0000899243-21-009657","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-009657","line_url":"/filing/0000899243-21-009657","is_derivative":false,"issuer_cik":"0001629383","issuer_name":"Berkeley Lights, Inc.","issuer_ticker":"BLI","issuer_name_source":null,"issuer_url":"/issuer/0001629383","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":61.13367969,"price_display":"61.13","price_state":"stated","total_value":611336.7969,"total_display":"611,336.80","total_whole":"611,337","shares_owned_after":6227.0,"shares_owned_after_display":"6,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider","n_lines":3},{"id":8298482,"accession":"0001209191-19-042401","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-042401","line_url":"/filing/0001209191-19-042401#line-1","is_derivative":false,"issuer_cik":"0001629383","issuer_name":"AKCEA THERAPEUTICS, INC.","issuer_ticker":"AKCA","issuer_name_source":null,"issuer_url":"/issuer/0001629383","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1819.0,"shares_display":"1,819","price_per_share":23.52,"price_display":"23.52","price_state":"stated","total_value":42782.88,"total_display":"42,782.88","total_whole":"42,783","shares_owned_after":19888.0,"shares_owned_after_display":"19,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-17","scope":"insider"},{"id":6618439,"accession":"0000874015-18-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-18-000020","line_url":"/filing/0000874015-18-000020#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2196.0,"shares_display":"2,196","price_per_share":51.76,"price_display":"51.76","price_state":"stated","total_value":113664.96,"total_display":"113,664.96","total_whole":"113,665","shares_owned_after":8931.0,"shares_owned_after_display":"8,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-17","scope":"insider"},{"id":5273059,"accession":"0000874015-17-000017","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-17-000017","line_url":"/filing/0000874015-17-000017","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1361.0,"shares_display":"1,361","price_per_share":46.29,"price_display":"46.29","price_state":"stated","total_value":63000.69,"total_display":"63,000.69","total_whole":"63,001","shares_owned_after":4463.0,"shares_owned_after_display":"4,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-18","scope":"insider","n_lines":2},{"id":3306524,"accession":"0000874015-16-000102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-16-000102","line_url":"/filing/0000874015-16-000102#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001629383","owner_name":"Boyce Sarah","owner_display_name":"Boyce Sarah","owner_url":"/insider/0001629383","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":872.0,"shares_display":"872","price_per_share":41.4574,"price_display":"41.46","price_state":"stated","total_value":36150.8528,"total_display":"36,150.85","total_whole":"36,151","shares_owned_after":1735.0,"shares_owned_after_display":"1,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-19","filed_date":"2016-01-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":37,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001599901","name":"Avidity Biosciences, Inc.","url":"/issuer/0001599901","role":"Director, Officer (President and CEO)","n_filings":21,"first_seen":"2022-08-17","last_seen":"2026-01-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001846253","name":"OmniAb, Inc.","url":"/issuer/0001846253","role":"Director","n_filings":1,"first_seen":"2022-11-14","last_seen":"2022-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001689657","name":"Berkeley Lights, Inc.","url":"/issuer/0001689657","role":"Director","n_filings":1,"first_seen":"2021-03-03","last_seen":"2021-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001662524","name":"AKCEA THERAPEUTICS, INC.","url":"/issuer/0001662524","role":"Director, Officer (President)","n_filings":1,"first_seen":"2019-07-17","last_seen":"2019-07-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000874015","name":"IONIS PHARMACEUTICALS INC","url":"/issuer/0000874015","role":"Officer (Chief Business Officer)","n_filings":3,"first_seen":"2016-01-19","last_seen":"2018-01-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001629383","retrieved_at":"2026-08-25T07:33:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}